<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CRM197, ricerca sul cancro, tumore, scelta di cura &#187; Pubblicazioni Scientifiche</title>
	<atom:link href="http://www.sceltadicura.it/category/documentazione/pubblicazioni-scientifiche/feed" rel="self" type="application/rss+xml" />
	<link>http://www.sceltadicura.it</link>
	<description>Associazione Scelta di Cura -CRM197.it</description>
	<lastBuildDate>Sat, 10 Dec 2011 10:28:02 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Pubblicazioni scientifiche del Dott. Buzzi</title>
		<link>http://www.sceltadicura.it/pubblicazioni-scientifiche-del-dott-buzzi</link>
		<comments>http://www.sceltadicura.it/pubblicazioni-scientifiche-del-dott-buzzi#comments</comments>
		<pubDate>Sun, 07 Oct 2007 00:11:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Documentazione]]></category>
		<category><![CDATA[Pubblicazioni Scientifiche]]></category>
		<category><![CDATA[CANCER IMMUNOLOGY]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[crm197]]></category>
		<category><![CDATA[cura cancro]]></category>
		<category><![CDATA[cura tumore]]></category>
		<category><![CDATA[Diphtheria Toxin]]></category>
		<category><![CDATA[IMMUNOTHERAPY]]></category>
		<category><![CDATA[potenzialità antitumorali e antiplacca della molecola CRM197]]></category>
		<category><![CDATA[ricerca sul cancro]]></category>
		<category><![CDATA[silvio buzzi]]></category>
		<category><![CDATA[terapia cancro]]></category>
		<category><![CDATA[terapia tumore]]></category>
		<category><![CDATA[THERAPY]]></category>

		<guid isPermaLink="false">http://www.sceltadicura.it/?p=64</guid>
		<description><![CDATA[*CANCER RESEARCH* anno 1973 *Inhibition of Growth of Ehrlich Tumors in Swiss Mice by Diphtheria Toxin* *CANCER RESEARCH* anno 1974 *Cancer Immunity after Treatment of Ehrlich Tumor with Diphtheria Toxin* Buzzi S. Diphtheria toxin in cancer therapy. Lancet I: 628-629, 1974 (letter). Buzzi S, Baccini C, Bubboli D, et al. Phase I-II study of CRM197 [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://cancerres.aacrjournals.org/cgi/reprint/33/10/2349" target="_blank">*CANCER RESEARCH* anno 1973 *Inhibition of Growth of Ehrlich Tumors in Swiss Mice by Diphtheria Toxin*</a></p>
<p><a href="http://cancerres.aacrjournals.org/cgi/reprint/34/12/3481.pdf" target="_blank">*CANCER RESEARCH* anno 1974 *Cancer Immunity after Treatment of Ehrlich Tumor with Diphtheria Toxin*</a></p>
<h6><font face="Comic Sans MS" size="4" color="#0000ff"><span style="font-size: 10pt"><font color="#000000"><font face="Times New Roman">Buzzi S. Diphtheria toxin in cancer    therapy. <em>Lancet I: 628-629, 1974    (letter).</em></font></font></span></font></h6>
<h6><font face="Comic Sans MS" size="4" color="#0000ff"><font color="#000000"><font face="Times New Roman"><span style="font-size: 10pt">Buzzi S, Baccini C, Bubboli D,    et al. </span><span style="font-size: 10pt">Phase I-II study of CRM197    administration to 50 advanced cancer patients<em>. Proc AACR- NCI-EORTC Internat Conf ,    Washington, 1999.</em></span></font></font></font></h6>
<p><a href="http://cancerres.aacrjournals.org/cgi/reprint/42/5/2054" target="_blank">*CANCER RESEARCH* anno 1982 *Diphtheria Toxin Treatment of Human Advanced Cancer*</a> </p>
<p><a href="http://www.crm197.it/ingenta.pdf" target="_blank">*CANCER IMMUNOLOGY, IMMUNOTHERAPY*  anno 2004 *CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients*</a> </p>
<p><a href="http://www.future-drugs.com/doi/pdf/10.1586/14750708.1.1.61" target="_blank">* THERAPY * anno 2004 *CRM197 and cancer: effects of intratumoral administration*</a></p>
<p><a href="http://www.crm197.it/therapy.pdf" target="_blank">*THERAPY *anno 2007 *CRM197: reduction of atherosclerotic stenoses in carotids of three  elderly patients*</a> </p>
<p>&nbsp;</p>
<p>altri Autori / other authors:</p>
<p>&nbsp;</p>
<h3><a href="http://www.ncbi.nlm.nih.gov/pubmed/18463770" target="_blank">[Heparin-binding epidermal growth factor (HB-EGF): myth or reality?]</a></h3>
<p><strong>Scuderi R</strong>, <strong>Failla A</strong>. </p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.sceltadicura.it/pubblicazioni-scientifiche-del-dott-buzzi/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

